A technically focused cannabis company. It's subsidiary, Terranueva Pharma utilizes smart, computerized cultivation techniques and R&D to produce consistent, quality products with lower overheads. Terranueva has a concentrated business strategy to meet the needs of 80% of the cannabis Canadian market. Using investment in R&D, the company is developing a higher quality cannabis that meets the primary motivations of consumers: Chronic pain, Migraines, Sleep disorders and Anxiety.